HomePVLA • NASDAQ
add
Palvella Therapeutics Inc
Previous close
$23.49
Day range
$23.52 - $25.88
Year range
$6.28 - $29.27
Market cap
280.81M USD
Avg Volume
68.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.87M | 347.47% |
Net income | -8.18M | -222.75% |
Net profit margin | — | — |
Earnings per share | -0.74 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.63M | 928.93% |
Total assets | 79.44M | — |
Total liabilities | 23.86M | — |
Total equity | 55.58M | — |
Shares outstanding | 11.06M | — |
Price to book | 4.66 | — |
Return on assets | -23.47% | — |
Return on capital | -27.47% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.18M | -222.75% |
Cash from operations | -6.77M | -514.16% |
Cash from investing | — | — |
Cash from financing | -1.20M | — |
Net change in cash | -7.98M | -623.77% |
Free cash flow | -6.82M | — |
About
Website
Employees
14
